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ABSTRACT
Objective: The current study aimed to identify the
barriers to participation among high-risk individuals in
the UK Lung Cancer Screening (UKLS) pilot trial.
Setting: The UKLS pilot trial is a randomised
controlled trial of low-dose CT (LDCT) screening that
has recruited high-risk people using a population
approach in the Cambridge and Liverpool areas.
Participants: High-risk individuals aged 50–75 years
were invited to participate in UKLS. Individuals were
excluded if a LDCT scan was performed within the last
year, if they were unable to provide consent, or if LDCT
screening was unable to be carried out due to
coexisting comorbidities.
Outcome measures: Statistical associations between
individual characteristics and UKLS uptake were
examined using multivariable regression modelling. In
those who completed a non-participation questionnaire
(NPQ), thematic analysis of free-text data was
undertaken to identify reasons for not taking part, with
subsequent exploratory linkage of key themes to risk
factors for non-uptake.
Results: Comparative data were available from 4061
high-risk individuals who consented to participate in
the trial and 2756 who declined participation. Of those
declining participation, 748 (27.1%) completed a NPQ.
Factors associated with non-uptake included: female
gender (OR=0.64, p<0.001), older age (OR=0.73,
p<0.001), current smoking (OR=0.70, p<0.001), lower
socioeconomic group (OR=0.56, p<0.001) and higher
affective risk perception (OR=0.52, p<0.001). Among
non-participants who provided a reason, two main
themes emerged reflecting practical and emotional
barriers. Smokers were more likely to report emotional
barriers to participation.
Conclusions: A profile of risk factors for non-
participation in lung screening has emerged, with
underlying reasons largely relating to practical and
emotional barriers. Strategies for engaging high-risk,
hard-to-reach groups are critical for the equitable
uptake of a potential future lung cancer screening
programme.
Trial registration number: The UKLS trial was
registered with the International Standard Randomised
Controlled Trial Register under the reference
78513845.
INTRODUCTION
Lung cancer is the leading cause of cancer
death in the UK, with approximately 35 000
deaths a year.1 The overall 5-year survival rate
is less than 10%, largely due to most patients
presenting with late-stage disease when treat-
ment has little effect on survival.1 Lung
screening is not yet available as a routine
screening programme in the UK, but is
being evaluated in a pilot trial. The UK Lung
Cancer Screening (UKLS) pilot trial com-
pares a single low-dose CT (LDCT) scan with
Strengths and limitations of this study
▪ To the best of our knowledge, this study is the
first to use a mixed methods approach to
examine the barriers to participation among
high-risk individuals in a lung cancer screening
trial.
▪ The study highlighted important subgroups with
low uptake of lung cancer screening and in
whom lung cancer risk is known to be higher.
▪ Increasing uptake among these high-risk groups
is key to implementing an equitable lung cancer
screening programme.
▪ Methodological issues associated with response
bias are acknowledged, whereby there was an
under-representation of younger individuals, indi-
viduals from lower socioeconomic groups, and
smokers in those completing the non-
participation questionnaire.
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usual care.2 LDCT was introduced in the late 1990s and
offers a major advance in imaging technology.3 It is
more sensitive than chest X-ray and has enabled detec-
tion of small, asymptomatic lung tumours.4 5 The
US-based National Lung Cancer Screening Trial (NLST)
showed that LDCT screening resulted in a 20% reduc-
tion in lung cancer-related mortality when compared
with chest radiography.6 Results from the on-going
Dutch-Belgian lung cancer screening trial (NELSON),
investigating whether LDCT screening reduces mortality
compared with no screening at 10 years follow-up, are
yet to be published.
Compared with routine screening for other types of
cancers, lung screening in the UKLS trial was only avail-
able to high-risk individuals as part of a two-stage popu-
lation risk screening strategy. It has previously been
shown that individuals from lower socioeconomic
groups, smokers and younger individuals were less likely
to take part at the ﬁrst stage of recruitment to the UKLS
trial.7 However, the factors affecting uptake of these
initial recruits who were subsequently identiﬁed as being
at high risk of developing lung cancer have not been
examined.
Inequalities in participation present a signiﬁcant chal-
lenge to the successful implementation of cancer screen-
ing programmes. Reduced uptake of participants for
cancer screening has been consistently found among
deprived populations and ethnic minority groups,8 9 and
previous studies have highlighted some of the barriers
and facilitators to lung screening.10–12 Van den Bergh
et al10 found that participants in the NELSON had a
more positive attitude towards the beneﬁts of lung cancer
screening, as well as a higher affective risk perception,
when compared with non-participants. Silvestri et al11
found that smokers were less likely to participate in
screening than non-smokers, due to lower perceived
effectiveness of lung cancer early detection strategies. A
qualitative study described four typological behaviours
among those declining participation in a lung cancer
screening programme: individuals who felt they were ‘too
old to beneﬁt’, ‘avoiders’ who preferred not to know
their lung cancer status, ‘worriers’ who felt that participa-
tion would increase their anxieties, and ‘fatalists’ who
believed that if they were to develop lung cancer, this
would occur regardless of being screened or not.12
The inﬂuence of affective risk perception on screen-
ing uptake is particularly relevant in the context of a tar-
geted screening strategy to identify those at high risk of
developing lung cancer. Affective risk perception refers
to an individual’s degree of concern or worry associated
with personal risk, rather than a quantitative estimate of
their risk.13 There is much debate about whether higher
affective risk perception motivates or deters individuals
from cancer screening. Studies including the NELSON
have shown that individuals with a higher affective risk
of lung cancer are more interested in taking part in
screening.14 15 However, a body of evidence regarding
uptake of other forms of cancer screening suggests that
a moderate level of affective risk perception optimises
screening uptake, with too little creating a lack of motiv-
ation and too much leading to avoidance of
screening.16 17
The aim of the current study was to use a mixed
methods approach to identify the barriers to uptake
among high-risk individuals invited to participate in
UKLS. We aimed to answer three questions: (1) What
are the demographic and psychological characteristics of
individuals declining participation at the second stage of
the UKLS trial? (2) Among those declining and stating
their reason, what are the reported barriers to participa-
tion? (3) Are there any associations between individual
characteristics and self-reported barriers to participa-
tion? It was hypothesised that declining to take part in
UKLS would be associated with lower socioeconomic
group, smoking, and higher affective risk perception.
Identifying barriers to participation among high-risk
individuals in the UKLS trial will inform the implemen-
tation of a potential national lung cancer screening
programme.
METHODS
Procedures
UKLS is a multicentre randomised controlled pilot trial
to compare the intervention of LDCT screening versus
usual care for the early detection of lung cancer in high-
risk individuals.2 Individuals from six primary care trusts
(PCTs) in Liverpool and Cambridge were approached
with an invitation letter and a participation question-
naire. The invitation packs were posted by the data man-
agement company using the respective PCT-headed
notepaper. The Liverpool Lung Project (LLP) risk algo-
rithm was used to identify individuals with >5% risk of
developing lung cancer over 5 years.18 This model incor-
porates age, sex, family history of lung cancer, smoking
duration, personal history of other cancers and non-
malignant respiratory disease, and occupational expos-
ure to asbestos.
High-risk individuals who consented to take part in
the screening trial were referred to as ‘positive uptake’,
while those who declined participation immediately fol-
lowing risk assessment were referred to as ‘non-uptake’.
Positive uptake individuals were invited to a recruitment
centre (at either Liverpool Heart and Chest Hospital or
Papworth Hospital), where they were given further infor-
mation about the trial, provided written informed
consent, and completed a touchscreen questionnaire.
Non-uptake individuals were asked to complete a paper-
based optional non-participation questionnaire (NPQ)
and return it using a freepost envelope attached. The
NPQ contained six closed response items and one free-
text item (see online supplementary appendix S1).
Participants
High-risk individuals aged 50–75 years residing in six
PCTs in the Cambridge and Liverpool areas, and able to
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provide written informed consent were included in the
study. Individuals were excluded from the UKLS trial if a
LDCT scan of the chest had been performed within the
previous year of invitation or they were unable to
provide consent. Individuals with comorbidities that con-
traindicated either screening or treatment if lung cancer
was detected were also excluded, as were those unable
to lie ﬂat or weighing greater than 200 kg.
Measures
Age and gender
Age and gender were provided by PCTs via the data
management company RADAR. Age referred to age at
time of risk calculation and was analysed using three cat-
egories: ≤65 years (younger), 66–70 years (recently
retired) and ≥71 years (older).
Socioeconomic group
Participants’ postcodes were used by the data manage-
ment company to provide Index of Multiple Deprivation
(IMD) ranks. IMD ranks were analysed using standard
quintiles based on England-wide population data—quin-
tile 1: 1–6496; quintile 2: 6497–12 993; quintile 3:
12 994–19 489; quintile 4: 19 490–25 986 and quintile 5:
25 987–32 482.19 Quintile 1 reﬂects those most deprived
(lowest socioeconomic group) and quintile 5 those least
deprived (highest socioeconomic group).
Smoking status
Smoking status data were collected at the ﬁrst stage of
the UKLS trial, and analysed using three categories:
‘current smoker’, ‘ex-smoker’, and ‘never-smoker’. Very few
high-risk participants had never smoked, hence this cat-
egory was excluded during analyses.
Affective risk perception
Affective risk perception was measured using 1 item
taken from the revised 6-item Cancer Worry Scale20 21
and refers to the degree of concern associated with per-
sonal risk of lung cancer. Data were collected from the
NPQ for NPQ completers, and from the touchscreen
questionnaire at the recruitment centre for positive
uptake individuals. Data were unavailable for NPQ non-
completers. Participants were asked to rate how con-
cerned they were about the possibility of getting lung
cancer someday. Response options included ‘not at all’,
‘somewhat’, ‘moderately’ and ‘very’ concerned. Three categor-
ies of affective risk perception were created: none (‘not
at all’ concerned), lower (‘somewhat’ concerned), and
higher (‘moderately’ or ‘very’ concerned).
Reason for non-participation
Qualitative data regarding reason(s) for non-participation
were gathered using an optional free-text question within
the NPQ (“If you would like to tell us your reason for not
taking part in the UKLS trial, please write it here”).
Analyses
Associations between individual characteristics and screen-
ing uptake were analysed using univariable logistic regres-
sion. To determine the effect of missing data on results,
sensitivity analyses of augmented data sets were under-
taken. For each variable with missing data >5%, this
involved coding the missing data as each potential
response, and determining whether there was a difference
in outcome between each augmented data set. If for each
augmented data set there was no statistically signiﬁcant dif-
ference in the outcome, missing data were determined as
having no statistically signiﬁcant effect on the pattern of
results and were, therefore, excluded from analyses.
Demographic and psychological characteristics found
to have statistically signiﬁcant associations in univariable
analyses (p<0.05) were included in a multivariable logis-
tic regression to identify the key risk factors for non-
uptake. Demographic differences between NPQ comple-
ters and NPQ non-completers were compared using uni-
variable associations. Statistical analyses were conducted
using STATAV.12.
In individuals who provided a reason for non-uptake,
free-text data were analysed to identify underlying
themes.22 A random sample of 25% of the data was inde-
pendently coded by another researcher (KJL), and dis-
crepancies were resolved by discussion to reach
consensus. NVivo V.10 was used to manage the data.
Finally, exploratory regression analyses were undertaken
to assess associations between key risk factors and key
themes (reported by >5% of non-uptake individuals) in
high-risk individuals who declined screening.
RESULTS
Trial participation
Figure 1 shows the response rate and recruitment of
high-risk individuals in the UKLS trial. Of the 2762 non-
uptake individuals, ﬁve individuals were excluded due to
reported gender discrepancies and one individual was
reported as deceased. Therefore, of the 8729 high-risk
individuals, the current study included 4061 (46.5%)
individuals who consented to participate in the UKLS
trial and 2756 (31.6%) who declined participation.
Among those declining, 748 (27.1%) individuals com-
pleted the NPQ and of these 434 (58.0%) provided com-
ments in the optional free-text ﬁeld. Sensitivity analyses
revealed that missing data had no statistically signiﬁcant
effect on the pattern of results.
Factors influencing uptake among high-risk individuals
Age, gender, smoking status, and socioeconomic group
were statistically signiﬁcantly associated with lung cancer
screening uptake (see table 1). Women were less likely to
take part in screening compared with men (OR=0.64;
p<0.001), and current smokers were less likely to take
part than ex-smokers (OR=0.70, p<0.001). Older indivi-
duals were less likely to participate in screening com-
pared with younger individuals aged ≤65 years (OR=0.73,
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p<0.001) and those recently retired (OR=0.76, p<0.001),
but the difference in uptake between younger individuals
and those recently retired was not statistically signiﬁcant.
Individuals in the highest socioeconomic group
(quintile 5) were most likely to participate in screening.
Individuals in the lowest quintile were almost twice as
likely to decline screening compared with those in the
highest quintile (OR=0.56, p<0.001).
Figure 1 Consort diagram showing response rate and recruitment of high-risk individuals in the UKLS trial (NPQ,
non-participation questionnaire; UKLS, UK Lung Cancer Screening).
Table 1 Univariable and multivariable analyses of factors influencing lung-screening uptake in high-risk individuals
Non-uptake
(n=2756)
n (%)
Positive
uptake
(n=4061)
n (%)
Univariable OR
(95% CI) p Value
Multivariable OR
(95% CI)† p Value
Gender
Male 1770 (64.2) 3041 (74.9) 1.00 (REF)
Female 986 (35.8) 1020 (25.1) 0.60 (0.54 to 0.67) <0.001*** 0.64 (0.58 to 0.71) <0.001***
Age range
Younger age (≤65 years) 838 (30.4) 1249 (30.8) 1.00 (REF)
Recently retired (66–70 years) 1087 (39.4) 1742 (42.9) 1.08 (0.96 to 1.21) 0.225 1.05 (0.93 to 1.18) 0.47
Older population (≥71 years) 831 (30.2) 1070 (26.3) 0.86 (0.76 to 0.98) 0.023* 0.73 (0.64 to 0.80) <0.001***
Older compared with recently
retired
831 (30.2) 1070 (26.3) 0.80 (0.71 to 0.90) <0.001*** 0.70 (0.62 to 0.79) <0.001***
Smoking status
Current smoker 1334 (48.4) 1568 (38.6) 0.67 (0.61 to 0.74) <0.001*** 0.70 (0.63 to 0.78) <0.001***
Ex-smoker 1418 (51.5) 2591 (61.3) 1.00 (REF)
Never-smoked‡ 4 (0.1) 2 (0.0) (–)
Socioeconomic group
Quintile 1 (most deprived) 924 (33.5) 1090 (26.8) 0.52 (0.45 to 0.60) <0.001*** 0.56 (0.49 to 0.65) <0.001***
Quintile 2 448 (16.3) 487 (12.0) 0.48 (0.40 to 0.57) <0.001*** 0.49 (0.42 to 0.59) <0.001***
Quintile 3 483 (17.5) 723 (17.8) 0.66 (0.56 to 0.77) <0.001*** 0.68 (0.58 to 0.80) <0.001***
Quintile 4 447 (16.2) 732 (18.0) 0.72 (0.61 to 0.85) <0.001*** 0.73 (0.62 to 0.86) <0.001***
Quintile 5 (least deprived) 453 (16.4) 1029 (25.3) 1.00 (REF)
*p<0.05, ***p<0.001.
†Adjusted for all other variables in model.
‡Smoking status data <2% excluded from statistical analyses.
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Table 2 compares affective risk perception between
non-uptake NPQ completers and positive uptake groups.
Individuals with a higher affective risk perception were
less likely to take part in lung cancer screening, when
compared with individuals reporting no or lower levels
of affective risk perception (OR=0.52, p<0.001 and
OR=0.64, p<0.001, respectively, after adjusting for age,
gender, smoking status and socioeconomic group).
There was no statistically signiﬁcant difference between
none and lower levels of affective risk perception.
Effects of NPQ completion versus non-completion
Among high-risk individuals declining participation in
the UKLS trial, older individuals were more likely than
younger individuals to complete the NPQ (OR=2.15,
p<0.001), as were ex-smokers compared with current
smokers (OR=1.49, p<0.001) (see online supplementary
appendix S2). Individuals of the lowest socioeconomic
group were less likely to complete the NPQ compared
with individuals of the highest socioeconomic group
(OR=0.65, p=0.001).
Self-reported barriers to participation among high-risk
non-uptake individuals
Six overarching themes were identiﬁed: practical bar-
riers, emotional barriers, age, trial acceptability, low per-
ceived risk and dislikes. An overview of the different
themes and subcategories is shown in table 3, with illus-
trative quotes provided for the two main themes reﬂect-
ing practical barriers and emotional barriers. The κ
coefﬁcient was 0.88 and discrepant coding was resolved
through discussion.
Practical barriers
The most commonly reported reasons for non-
participation in high-risk non-uptake individuals were
practical barriers (see box 1), including travel with difﬁ-
culties relating to the distance of travel, lack of public
transport available, and the cost of either the journey
itself or hospital parking. Comorbidities were also a
commonly reported practical barrier to participation,
with individuals feeling that either their current
comorbidity or related treatments prevented them from
attending hospital to participate in the trial. Other com-
monly reported practical barriers included carer responsi-
bilities, already receiving screening, and not being in the area.
Emotional barriers
Emotional barriers most commonly included avoidance of
lung cancer information and fear (see box 2).
Trial acceptability, age, dislikes and low perceived risk
Trial acceptability was mentioned as a reason for non-
participation—some individuals felt that the duration or
frequency of the trial was not practical, and others did
not want to take part as there was potential to not
receive the intervention of a LDCT scan. Age was also
described as a reason for not taking part, with some
individuals stating that they were above the desired age
range (50–75 years), while others felt that they were “too
old”. Some individuals mentioned dislikes for hospitals,
healthcare system, or scans and tests. Low perceived risk
was also reported, with most of these responses relating
to either no longer smoking or smoking too few cigar-
ettes to warrant lung cancer screening.
Exploratory associations between risk factors and
self-reported barriers to participation
Among those declining to participate, the odds of report-
ing travel as a barrier were more than double in quintiles
3–5 when compared with quintile 1 (OR=2.37, p=0.005;
OR=2.91, p<0.001; OR=2.25, p=0.009, respectively) (see
online supplementary appendix S3). Individuals with a
higher affective risk perception were more likely to
report comorbidities as a barrier to participation
(OR=1.84, p=0.005). Smokers were less likely to report
practical barriers such as already receiving scans, work/
other commitments and not being in the area (OR=0.48,
p=0.002), and more likely to report emotional barriers as
reasons for non-participation (OR=2.02, p=0.013)
Table 2 Univariable and multivariable analyses of level of affective risk perception influencing lung screening uptake in
high-risk individuals
NPQ
completers
(n=748)
n (%)
Positive
uptake
(n=4061)
n (%)
Univariable OR
(95% CI) p Value
Multivariable OR
(95% CI) † p Value
Affective risk perception
None (not at all concerned) 129 (17.2) 1054 (26.0) 1.00 (REF)
Lower (somewhat concerned) 213 (28.5) 1493 (36.8) 0.86 (0.69 to 1.09) 0.219 0.82 (0.65 to 1.04) 0.094
Higher (moderately or very
concerned)
329 (44.0) 1478 (36.4) 0.55 (0.45 to 0.69) <0.001*** 0.52 (0.42 to 0.65) <0.001***
Higher compared with lower 329 (44.0) 1478 (36.4) 0.64 (0.53 to 0.77) <0.001*** 0.64 (0.53 to 0.77) <0.001***
Missing 77 (10.3) 36 (0.9) (–)
***p<0.001.
†Adjusted for age, gender, smoking status and socioeconomic group.
NPQ, non-participation questionnaire.
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compared with ex-smokers. Emotional barriers were also
more likely to be reported by older individuals (OR=2.94,
p=0.036). Associations between gender and self-reported
barriers were not statistically signiﬁcant.
DISCUSSION
To the best of our knowledge, the current study is the ﬁrst
to use a mixed methods approach to examine the barriers
to participation among high-risk individuals in a lung
cancer screening trial. A proﬁle of potential risk factors for
non-uptake of lung screening was revealed. High-risk indi-
viduals who were older, female, smokers, from a lower
socioeconomic group, or with a higher affective risk per-
ception were less willing to participate in the UKLS trial.
Practical barriers reﬂecting difﬁculties with travelling to
attend screening, comorbid illnesses and treatments, and
carer responsibilities were the most common self-reported
reasons for non-participation. Exploratory analysis
revealed that travel was a more commonly reported barrier
among individuals of higher socioeconomic group, and
individuals with a higher affective risk perception more
commonly reported barriers relating to comorbidities.
Smokers were more likely to report emotional barriers as
reasons for non-participation.
Table 3 Self-reported reasons for non-participation in the UKLS trial
Theme
NPQ completers
(n=748) n (%) Subcategory* n
Practical barriers 350 (46.8) Travel 138
Comorbidities 120
Carer responsibilities 43
Already receiving scans 41
Work and other commitments 23
Not in area 20
Taking part in other research 8
Language or literacy problems 6
Cannot be scanned 4
Prior exposure to radiation 3
Effort required 5
Emotional barriers 138 (18.4) Avoidance of lung cancer information 17
Fear 15
Anxiety from taking part or results 6
Mistrust of medical system 2
Recent bereavement 2
Anxiety of family member 1
Trial acceptability 18 (2.4) Trial acceptability 1
Duration or frequency 11
Unwilling to be randomised 6
Age 16 (2.1) Age 10
Too old 6
Dislikes 13 (1.7) Hospital or healthcare system 9
Scans and tests 4
Low perceived risk 12 (1.6) Low perceived risk 12
Other 30 (4.0) No reason stated 23
Already have/had lung cancer 4
Would like to take part 2
Thought request was for partner 1
*Some individuals provided more than one answer, and were therefore counted in more than one subcategory.
NPQ, non-participation questionnaire; UKLS, UK Lung Cancer Screening.
Box 1 Practical barriers
“I would like to take part but I do not have a car and it is very dif-
ficult to get to Papworth—involves train and taxi or two buses
and a couple of hours each way”
“I am being admitted to hospital on December 2nd 2011 for hip
replacement otherwise I would have been happy to participate”
“I have a heart problem and gastric problems and in the last
3 years I have had CT scans and X-rays, and I am going to have
another CT scan in Feb this year 2012. So it’s for these reasons
that I do not wish to take part”
Box 2 Emotional barriers
“I do not wish to know if I had lung cancer, so I try not to think
about it”
“Frightened”
“Would be anxious and worried about actually taking part in the
physical research project. Sorry”
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At the initial stage of recruitment from the general
population into the UKLS trial, uptake generally
increased with age, with the exception of individuals
aged ≥71 years where uptake was the lowest.7 In contrast,
no difference in screening uptake was observed between
younger and recently retired high-risk individuals in the
current study, although older individuals were less likely
to participate in screening. Reduced uptake among
older individuals in both stages of the UKLS trial is
important, since more than half of lung cancer cases
occur in individuals aged over 70 years.23
High-risk women were less likely than high-risk men to
participate in the UKLS trial. Currently the only UK
screening programme that recruits both genders is the
colorectal screening programme. Although initial
uptake of faecal occult blood testing is higher among
women, they are less likely than men to take further
testing involving sigmoidoscopy.24–26 It can be argued
that being recalled for ﬂexible sigmoidoscopy infers
high risk similar to that of being invited back to partici-
pate in the UKLS trial; both of these may provoke fear
and concerns related to lung cancer. Previous studies
have found cancer-related fears and concerns to be
more prevalent among women than men.27 28
The association between smoking status and trial
uptake is consistent with previous studies that revealed
lower uptake in lung cancer screening among
smokers.7 11 12 Exploratory analyses found that smokers
were more likely to report emotional than practical bar-
riers when compared with ex-smokers, reﬂecting fear,
anxiety and a wish to avoid lung cancer-related informa-
tion. Similarly, Silvestri et al11 found that when compared
with never-smokers, current smokers reported more
fatalistic attitudes and were less likely to believe that
early detection and intervention would result in a good
chance of survival.
In contrast to van den Bergh et al10 who found that a
higher affective risk perception was a motivator for lung
screening in the NELSON, the current study found that
high-risk individuals with a higher affective risk percep-
tion were less likely to participate in the UKLS trial. It is
likely, therefore, that a high-risk status was inferred,
which for some individuals induced avoidance of cancer-
related information. This is consistent with previous
studies which report that higher levels of concern or
threat associated with personal cancer risk may act as a
deterrent to screening through the mechanism of
avoidance.16 17
The association between lower socioeconomic group
and lower screening uptake among high-risk individuals
echoes that of previous studies.8 9 29 The effect of socio-
economic deprivation on screening uptake has been
attributed in part to fearful and fatalistic beliefs among
more deprived populations.30 31 Such beliefs may partly
stem from, and be reinforced by, greater exposure to
lung cancer and other prevalent respiratory diseases in
deprived communities as a consequence of socio-
economic differences in tobacco use.32 33
Previous studies have found travel to be an important
barrier to participation in cancer screening.12 34 In the
current study, difﬁculties with travel were more com-
monly reported by higher, rather than lower, socio-
economic groups. However, we suggest that this
counterintuitive ﬁnding is a confound of geographical
area rather than a true effect, reﬂecting difﬁculty in trav-
elling to Papworth Hospital—located in rural and more
afﬂuent Cambridgeshire—compared with Liverpool
Heart and Chest Hospital.35
The use of a mixed methods approach allowed for a
richer exploration of the barriers to lung screening
uptake than quantitative or qualitative analysis alone.36 In
addition, the use of free-text comments in a question-
naire provided an opportunity for data to be gathered
from a large sample of individuals, and from those who
may not be willing or able to participate in interviews or
focus groups.37 38 However, methodological issues asso-
ciated with response bias are acknowledged. Younger
individuals, those from lower socioeconomic groups, and
smokers were less likely to complete the NPQ. As a result,
there was an under-representation of self-reported bar-
riers in these individuals. In addition, individuals may not
be consciously aware of underlying motivations for their
behaviour.39 Some barriers might be perceived as more
legitimate than others, and emotional barriers relating to
avoidance, fear and anxiety may, therefore, have been
under-reported. Further qualitative studies are needed to
gain an in-depth understanding of barriers and facilita-
tors to lung cancer screening in high-risk individuals.
Smoking status was computed from self-reported infor-
mation; so there is potential for smokers to be under-
represented, although previous studies have shown the
validity of self-reported smoking status to be high.40 41
Affective risk perception was assessed using one item
from the revised Cancer Worry Scale.20 21 The use of
this single-item measure in predicting level of affective
risk perception has not yet been validated.
Although randomised trials are the gold standard for
evidence-based decision-making in medicine,42 an indivi-
dual’s decision about participating in a trial is different
from deciding to participate in a national screening pro-
gramme. As a result, there may be limitations regarding
the generalisability of results to the general population
when a national lung cancer screening programme is
implemented in practice, and also a risk of amplifying
the effects of sociodemographic variables on non-
uptake, as observed in the current trial.
CONCLUSION
Strategies to improve equitable uptake are critical to the
successful implementation of new cancer screening pro-
grammes. The current study highlighted important sub-
groups who were less likely to take part in UKLS trial
and in whom lung cancer risk is known to be higher.23
In the case of a national lung cancer screening pro-
gramme, efforts to improve uptake should include
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strategies for engaging women and those most at risk,
including adults over 70 years, smokers, and those from
deprived areas. Practical barriers relating to access
should be addressed, with behavioural interventions
designed to minimise emotional barriers, especially
among current smokers.
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